Clinicians in across the UK are being urged by the British Acupuncture Council to consider referring their patients for acupuncture to treat a range of different conditions
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group provides a market perspective on the diabetes monitoring and drug delivery innovation fields and explains why these are a scenario for big technology synergy
The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
Paulus Carpelan, Vice President at Quattro Folia Oy argues that now is the time to rethink healthcare when it comes to the treatment of people with diabetes.
Researchers at Cleveland Clinic, University of Oxford, and University of Erlangen have identified a novel imaging biomarker – and found it can be used to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries
Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
Colin Capper, Head of Research Development and Evaluation at Alzheimer’s Society, discusses why greater investment is needed in today’s dementia care research
CARMAT today confirms the announcement by the National Research Center for Cardiac Surgery on the successful transplant of a donor heart in the first international patient implanted with the CARMAT heart in October 2017
Chester Medical school shed light on the link between obesity and diabetes, the challenge facing patients with ‘Diabesity’ and the research contribution of the school in solving this problem
Jonathan Evans, communications manager at the Association of British HealthTech Industries provides an interesting update on the health technology sector, including the extent to which the UK exports to the EU every year in this vein.
Prof Colin J Suckling OBE DSc FRSE, research professor of chemistry at the University of Strathclyde’s Department of Pure & Applied Chemistry shares his views on the challenge of commercialisation when it comes to research into medicinal chemistry
